Regencell Bioscience
RGC
$5.33
Share price
-9.20%
Change (1 day)
-79.43%
Change (1 year)
Categories
Regencell Bioscience (RGC) - Cash on Hand
Cash on Hand as of June 2023 : $11.56 M
According to Regencell Bioscience's latest financial reports the company has $11.56 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Regencell Bioscience - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $11.56 M | -29.56% |
| 2022-06-30 | $16.41 M | 27532% |
| 2021-06-30 | $0.05 M | -84.65% |
| 2020-06-30 | $0.38 M | 59.05% |
| 2019-06-30 | $0.24 M |